Georg Heß
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 85
- Hepatology 21
- Hepatitis C virus research 14
- Liver Diseases and Immunity 6
- Co-authors
- Dietmar Zdunek (22 shared papers)Andreas Viardot (17 shared papers)Karl‐Hermann Meyer zum Büschenfelde (21 shared papers)Michael Peter Manns (12 shared papers)Ralf Christian Bargou (7 shared papers)Hugo Albert Katus (8 shared papers)Kerstin Kurz (3 shared papers)Evangelos Giannitsis (3 shared papers)
- Journals
- Blood (58 papers)Journal of Medical Virology (11 papers)Journal of Clinical Oncology (8 papers)British Journal of Haematology (8 papers)Hepatology (7 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Georg Heß
225 papers receiving 11.2k citations
Georg Heß's Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 1.5k
- Pathology and Forensic Medicine 2.5k
- Genetics 665
- Neurology 926
- Hematology 742
Countries citing papers authored by Georg Heß
This map shows the geographic impact of Georg Heß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Heß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Heß more than expected).
Fields of papers citing papers by Georg Heß
This network shows the impact of papers produced by Georg Heß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Heß. The network helps show where Georg Heß may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Heß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent Hit paper breakdown → | 1996 | 1168 |
| 2 | Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody Hit paper breakdown → | 2008 | 900 |
| 3 | Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2009 | 540 |
| 4 | Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Hit paper breakdown → | 2016 | 490 |
| 5 | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study Hit paper breakdown → | 2015 | 468 |
| 6 | Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study Hit paper breakdown → | 2015 | 379 |
| 7 | Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study Hit paper breakdown → | 2016 | 368 |
| 8 | Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma Hit paper breakdown → | 2016 | 325 |
| 9 | 2017 | 294 | |
| 10 | 2010 | 285 | |
| 11 | 1997 | 275 | |
| 12 | 2004 | 218 | |
| 13 | 2007 | 157 | |
| 14 | 1989 | 155 | |
| 15 | 2016 | 139 | |
| 16 | 2013 | 135 | |
| 17 | 2018 | 132 | |
| 18 | 2022 | 120 | |
| 19 | 2017 | 118 | |
| 20 | 2004 | 116 |
About Georg Heß
Georg Heß is a scholar working on Pathology and Forensic Medicine, Hepatology, Hematology, Genetics and Epidemiology, having authored 237 papers that have together received 11.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (85 papers), Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (14 papers), Multiple Myeloma Research and Treatments (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), CNS Lymphoma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (6 papers) and Liver Diseases and Immunity (6 papers). The work is most often cited by research in Hepatology (1.5k citations), Pathology and Forensic Medicine (2.5k citations), Genetics (665 citations), Neurology (926 citations) and Hematology (742 citations). Georg Heß has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Dietmar Zdunek, Andreas Viardot, Karl‐Hermann Meyer zum Büschenfelde, Michael Peter Manns, Ralf Christian Bargou, Hugo Albert Katus, Kerstin Kurz, Evangelos Giannitsis, Martin Schüler and Bertrand Coiffier. Their work appears in journals such as Blood, Journal of Medical Virology, Journal of Clinical Oncology, British Journal of Haematology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.